Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Studies from University of Texas further understanding of cancer gene therapy
June 24th, 2008
Data detailed in 'In vivo and in vitro studies of anticancer actions of alpha-TEA for human prostate cancer cells' have been presented. "Vitamin E analog, 2,5,7,8-tetramethyl-2R-(4R,8R, 12-trimethyltridecyl) chroman-6-yloxyacetic acid, referred to as alpha-TEA induces apoptosis in a variety of human cancer cells in cell culture and reduces tumor burden and metastases in preclinical animal models of breast and ovarian cancer. The goal of this study was to determine in vivo anticancer efficacy of alpha-TEA against human prostate cancer cells and identify mechanisms of action," scientists in the United States report. "A PC-3-GFP xenograft model was used to assess the...
Source: Cancer Weekly (2008-06-24)
|
